Stereoisomer-specific inhibition of superoxide anion-induced rat aortic smooth-muscle cell proliferation by 17β-estradiol is estrogen receptor dependent

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 4, 1998, Pages 499-505

  Cathapermal, Sam ^a   Lavigne, Mark C ^a   Leong Son, Mann ^a   Alibadi, Thais ^a   Ramwell, Peter W ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aortic explants; Estradiol; Estrogen receptor; Proliferation; Superoxide anions; Vascular smooth muscle cells

Indexed keywords

17ALPHA ESTRADIOL; ESTRADIOL; ESTROGEN RECEPTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROGESTERONE; SUPEROXIDE; TESTOSTERONE;

ANIMAL CELL; AORTA MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ESTROGEN ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STEREOSPECIFICITY;

ANIMALS; AORTA, THORACIC; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; MALE; MUSCLE, SMOOTH, VASCULAR; POLYUNSATURATED ALKAMIDES; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; STEREOISOMERISM; SUPEROXIDES; TESTOSTERONE; THYMIDINE; XANTHINE OXIDASE;

EID: 0031955611     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199804000-00005     Document Type: Article

References (45)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-8.
2. Jackson CL, Schwartz SM. Pharmacology of smooth muscle cell replication. Hypertension 1992;20:713-36.
3. Yamaguchi H, Daida H, Yokoi H, et al. Effectiveness of probucol on preventing restenosis after percutaneous transluminal angioplasty. Cleveland Clinic Restenosis Summit, 1993;V:76.
4. Berk BC. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. Cleveland Clinic Restenosis Summit, 1994;VI:320-31.
5. Berk BC, Nunue GL, Sgoutas DE, et al. Vitamins C and E improve the response to coronary balloon injury in the pig. Cleveland Clinic Restenosis Summit 1994;VI:316.
6. Freeman BA, Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982;47:412-26.
7. Muehlematter D, Larsson R, Cerutti P. Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cells. Carcinogenesis 1988;9:239-45.
8. Shibanuma M, Kuroki T, Nose K. Induction of DNA replication and expression of proto-oncogene c-mvc and c-fos in quiescent Balb/3T3 cells by xanthine/xanthine oxidase. Oncogene 1988;3:17-21.
9. Varmus HE. The molecular genetics of cellular oncogenes. Annu Rev Gener 1984;18:553-612.
10. Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994;63:451-86.
11. Schuchard M, Landers JP, Sandhu NP, Spelsberg TC. Steroid hormone regulation of nuclear proto-oncogenes. Endocrinol Rev 1993;14:659-69.
12. Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976;36:4595-601.
13. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle proliferation of pig coronary artery. Br J Pharmacol 1993;109:612-7.
14. Levy H, Boas EP. Coronary artery disease in women. JAMA 1936; 107:97-102.
15. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten year follow-up from the Nurses Health Study. N Engl J Med 1991;325:756-62.
16. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996;10:615-24.
17. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994;19:722-6.
18. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-70.
19. Farhat MY, Vargas R, Dingaan B, Ramwell PW. In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium. Br J Pharmacol 1992;107:679-83.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265-75.
21. Van Gelder BF, Slater EC. The extinction coefficient of cytochrome c. Biochim Biophys Acta 1962;58:593-5.
22. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992;70:593-9.
23. Ross D, Cotgreave I, Moldeus P. The interaction of reduced glutathione with active oxygen species generated by xanthine-oxidase-catalyzed metabolism of xanthine. Biochim Biophys Acta 1985;841:278-82.
24. Tsushima RG, Moffat MP. Differential effects of purine/xanthine oxidase on the electrophysiologic characteristics of ventricular tissues. J Cardiovasc Pharmacol 1990;16:50-8.
25. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 1984;219:1-14.
26. Hamer I, Wattiaux R, Wattiaux-De Coninck S. Deleterious effects of xanthine oxidase on rat liver endothelial cells after ischemia/reperfusion. Biochim Biophys Acta 1995;1269:145-52.
27. Kong XJ, Lee SL, Lanzillo JJ, Fanburg BL. Cu, Zn Superoxide dismutase in vascular cells: changes during cell cycling and exposure to hyperoxia. Am J Physiol 1993;264:L365-75.
28. Cocharane CG, Schraufstater IU, Hyslop PA, Jackson J. Cellular and biochemical events in oxidant injury. In: Upjohn Symposium Proceedings: Oxygen Radicals. Kalamazoo, MI: Upjohn Pharmaceuticals, 1987:49-54.
29. Hyslop PA, Hinshaw DB, Hasley WA. Mechanisms of oxidant mediated cell injury: the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 1988;263:1665-75.
30. Moore S. Endothelial injury and atherosclerosis. Exp Mol Pathol 1979;31:182-90.
31. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995;75:487-517.
32. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986;58:427-44.
33. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
34. 2 in cultured rabbit aortic smooth muscle cells. Atherosclerosis 1988; 71:165-71.
35. Freisleben HJ, Packer L. Free-radical scavenging activities, interactions and recycling of antioxidants. Biochem Soc Trans 1993; 21: 325-30.
36. Halliwell B, Grootveld M. The measurement of free radical reactions in humans: some thoughts for future experimentation. FEBS Lett 1987;213:9-16.
37. Farhat MY, Abi-Younes S, Ramwell PW. Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol 1996;51:571-6.
38. Donohue TM Jr, Barker KL. Glucose-6-phosphate dehydrogenase: translational regulation of synthesis and regulation of processing of the enzyme in the uterus by estradiol. Biochim Biophys Acta 1983;739:148-57.
39. Thomas G, Ito K, Zikic E, Bhatti T, Han C, Ramwell PW. Specific inhibition of the contraction of the rat aorta by estradiol 17β. J Pharmacol Exp Ther 1995;273:1544-50.
40. Labate ME, Whelly SM. Barker KL. Ribosome-associated estradiol-binding components in the uterus and their relationship to the translational capacity of uterine ribosomes. Endocrinology 1986;119:140-51.
41. Grainger DJ, Weissberg PL, Metcalfe JC. Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor β. Biochem J 1993;294:109-12.
42. Orimo A, Inoue S, Ikegani A, et al. Vascular smooth muscle cells are targets for estrogen. Biochem Biophys Res Commun 1993;195:730-6.
43. Lin AL, Gonzalez R, Carey KD, Shain SA. Estradiol 17β affects estrogen receptor distribution and elevates progesterone receptor content in baboon aorta. Arteriosclerosis 1986;6:495-504.
44. Horwitz KB, Horwitz ID. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J Clin Invest 1982;69:750-9.
45. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89:1501-10.